Second slide

We focus on bringing essential medicines within the reach of populations within frontier markets, which are challenging to penetrate.

Through our intellectual property management, we rigorously study each market and establish the ideal product portfolio for registering in that market. This is an evolving cycle, where our onground feedback mechanisms continuously sharpen our ability to expand “What’s in-demand” and gives us the direction to pursue the correct product development that can allow us to serve the needs of local markets at a portfolio level.

Our Robust Registrations and Future Pipeline As of H1FY21